Aripiprazole (BMS-337039) for Outpatients With Schizophrenia Completing Aripiprazole Clinical Trials: A Non-Comparative Rollover Protocol
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Aripiprazole (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb; Otsuka America Pharmaceutical
- 13 Jan 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Feb 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 03 Feb 2010 Additional location (India) added as reported by Clinical Trials Registry - India.